|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.78 USD | -6.36% |
|
-3.90% | +5.62% |
| 01-15 | Guardian Pharmacy Services, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 04:30 PM | |
| 01-13 | Guardian Pharmacy Reiterates 2025 Guidance, Issues 2026 Outlook | MT |
| Capitalization | 2.15B 1.85B 1.67B 1.6B 2.92B 198B 3.06B 19.71B 7.88B 94.67B 8.07B 7.89B 339B | P/E ratio 2025 * |
50.4x | P/E ratio 2026 * | 35.5x |
|---|---|---|---|---|---|
| Enterprise value | 2.15B 1.85B 1.67B 1.6B 2.92B 198B 3.06B 19.71B 7.88B 94.67B 8.07B 7.89B 339B | EV / Sales 2025 * |
1.49x | EV / Sales 2026 * | 1.51x |
| Free-Float |
99.04% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Guardian Pharmacy Services, Inc.
| 1 day | -6.36% | ||
| 1 week | -3.90% | ||
| Current month | -5.16% | ||
| 1 month | -3.32% | ||
| 3 months | +6.79% | ||
| 6 months | +12.66% | ||
| Current year | +5.62% |
| 1 week | 31.29 |  | 35.15 |
| 1 month | 31.29 | | 35.15 |
| Current year | 26.34 | | 35.15 |
| 1 year | 17.78 | | 37.43 |
| 3 years | 14.16 | | 37.43 |
| 5 years | 14.16 | | 37.43 |
| 10 years | 14.16 | | 37.43 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kendall Forbes
COO | Chief Operating Officer | 70 | 30/06/2004 |
David Morris
DFI | Director of Finance/CFO | 63 | 20/07/2003 |
Fred Burke
CEO | Chief Executive Officer | 77 | 20/07/2003 |
| Director | Title | Age | Since |
|---|---|---|---|
William Bindley
CHM | Chairman | 85 | 20/07/2003 |
Fred Burke
BRD | Director/Board Member | 77 | 20/07/2003 |
David Morris
BRD | Director/Board Member | 63 | 20/07/2003 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.36% | -3.90% | +62.72% | - | 2.15B | |
| +1.89% | -14.26% | +25.23% | -21.04% | 19.5B | |
| +3.22% | -7.73% | -6.04% | -15.49% | 10.28B | |
| -0.33% | -5.88% | +3.10% | +10.31% | 6.09B | |
| -3.40% | -6.63% | -13.37% | +10.52% | 4.32B | |
| +2.28% | -1.94% | +3.66% | -30.73% | 4.09B | |
| -0.10% | -1.61% | -15.46% | -43.74% | 3.39B | |
| +0.76% | +1.12% | +35.29% | -36.20% | 3.25B | |
| -0.54% | -2.51% | -5.42% | +25.96% | 2.84B | |
| -2.09% | -5.92% | +7.99% | +28.22% | 1.82B | |
| Average | -0.47% | -4.46% | +9.77% | -8.02% | 5.77B | |
| Weighted average by Cap. | +0.79% | -8.59% | +10.43% | -13.09% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.44B 1.24B 1.12B 1.07B 1.95B 132B 2.05B 13.21B 5.28B 63.46B 5.41B 5.29B 227B | 1.42B 1.22B 1.1B 1.06B 1.93B 131B 2.02B 13.04B 5.21B 62.62B 5.33B 5.22B 224B |
| Net income | 43.87M 37.76M 34.01M 32.71M 59.51M 4.03B 62.41M 402M 161M 1.93B 165M 161M 6.92B | 58.83M 50.64M 45.61M 43.87M 79.8M 5.41B 83.68M 540M 216M 2.59B 221M 216M 9.28B |
| Net Debt | - | - |
Employees
3,400
Sector
Drug Retailers
Calendar
03-11 -
Earnings release - Q4 2025
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/03/26 | 31.78 $ | -6.36% | 200,911 |
| 05/03/26 | 33.94 $ | -2.36% | 222,161 |
| 04/03/26 | 34.76 $ | +2.12% | 217,152 |
| 03/03/26 | 34.04 $ | +1.13% | 220,316 |
| 02/03/26 | 33.66 $ | +0.45% | 113,699 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
33.94USD
Average target price
35.00USD
Spread / Average Target
+3.12%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GRDN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition